20 documents found, page 1 of 2
Anti-Osteoporotic Medication-Related Jaw Osteonecrosis
Ferreira Azevedo, Sofia; Pinto Oliveira, Cláudia; Prata, Ana Rita; Cunha, Inĕs; Barcelos, Anabela
Anti-Osteoporotic Medication-Related Jaw Osteonecrosis: A Descriptive Analysis ...
Ferreira Azevedo, Sofia; Pinto Oliveira, Cláudia; Prata, Ana Rita; Cunha, Inês; Barcelos, Anabela
Impact of Concordance Between Antinuclear Antibody Indirect Immunofluorescence ...
Pinto Oliveira, Cláudia; Pereira Silva, Mariana; Vilafanha, Carolina; Costa, Graça; Santos, Mariana Emília; Gonçalves, Maria João; Silva, PriscilaIdiopathic inflammatory myopathies (IIM) are a heterogeneous group of systemic autoimmune rheumatic disorders in which chronic inflammation of skeletal muscle leads to muscle weakness. Many other organs, including the skin, heart, lungs, and joints, may be affected. Patients with IIM may be positive for myositis antibodies (MAs), including myositis-specific and/or associated antibodies. Although helpful for est...
Biologic disease-modifying antirheumatic drugs survival in late-onset axial spo...
Silva, Susana P.; Monteiro, Beatriz; Oliveira, Cláudia Pinto; Costa, Roberto Pereira da; Matos, Carolina Ochôa; Lopes, Mariana DizObjectives Although axial spondyloarthritis (axSpA) typically begins before age 45, late-onset axSpA (lo-axSpA) has been widely recognized. While existing literature describes this subgroup, data on therapeutic approaches remain limited. Therefore, we aimed to evaluate the efficacy and safety of biologic DMARDs in patients with lo-axSpA.Methods We conducted a retrospective, multicentre, national cohort study us...
Hospitalization costs in Portugal among people with obesity
Destri, Kelli; Oliveira Henriques, Ana Rita; Mendonça, Nuno; Alves, Joana; Barcelos, Anabela; Dias, Sara Simões; Gregório, Maria João; Canhão, HelenaFunding Information: The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This study was funded by the Funda\u00E7\u00E3o para Ci\u00EAncia e Tecnologia, FCT, I. P. reference SFRH (PD/BD/135589/2018) and by Comprehensive Health Research Center (CHRC) (UIDP/04923/2020). Publisher Copyright: Copyright © 2024 Destri, Henriques, Mendonça, Alves,...
CheckAP
Oliveira Henriques, Ana Rita; M. Pimentel-Santos, F.; Teles de Sousa, João; Silva, Leandro; Gago, Laura; Santos, Mariana Emília; Teodósio Chícaro, AnaPublisher Copyright: © 2024, Sociedade Portuguesa de Reumatologia. All rights reserved.; Background: The percentage of Portuguese psoriasis patients with psoriatic arthritis is unknown but musculoskeletal complaints related to PsA affect up to a third of patients. Dermatologists can identify early PsA as skin symptoms often precede joint symptoms in 80% of patients. Efficient and easy to perform screening tools...
Polymyalgia Rheumatica After COVID-19 Vaccination: Data from the EudraVigilance...
Pinto Oliveira, Cláudia; Ferreira Azevedo, Sofia; Vilafanha, Carolina; Prata, Ana Rita; Barcelos, AnabelaN/a.; N/a.
Costs of Hip Fractures in Postmenopausal Women in Portugal: A Study from the Pa...
Barcelos, Anabela; Gonçalves, Judite; Mateus, Céu; Canhão, Helena; Rodrigues, Ana MariaN/a.; N/a.
Creation and Validation of the European Portuguese Version of the Systemic Lupu...
Ferreira, Pedro Lopes; Cunha, Rita Novais; Macieira, Carla; Fontes, Tomás; Inês, Luís; Maduro, Ana Isabel Ramos; Martins, Ana; Rajão, Frederico(1) Background: Patients with systemic lupus erythematous (SLE) experience profound effects on health-related quality of life (HRQoL) that cannot be explained by objective indicators of mortality and morbidity. This study aimed to adapt the SLE Quality of Life (SLEQoL) questionnaire to the European Portuguese population and to assess its reliability and validity for patients with SLE. (2) Methods: Two independe...
Creation and Validation of a Portuguese Version of the UCLA Scleroderma Clinica...
Ferreira, Pedro Lopes; Genrinho, Inês; Santiago, Tânia; Carones, Adriana; Mazeda, Carolina; Barcelos, Anabela; Beirão, Tiago; Costa, Flávio(1) Background: The UCLA GIT 2.0 questionnaire has been recognized as a feasible and reliable instrument to assess gastrointestinal (GI) symptoms in systemic sclerosis (SSc) patients and their impact on quality of life. The aim of this study was to create and validate UCLA GIT 2.0 for Portuguese patients with SSc. (2) Methods: A multi-center study was conducted enrolling SSc patients. UCLA GIT 2.0 was validated...